CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2019 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
CAPR on Nasdaq
Shares outstanding
45,782,552
Price per share
$28.86
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
14,454,900
Total reported value
$104,097,739
% of total 13F portfolios
0%
Share change
+723,225
Value change
+$3,051,758
Number of holders
114
Price from insider filings
$28.86
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.5% $38,658,889 2,966,914 BlackRock, Inc. 31 Dec 2024
VANGUARD GROUP INC 4.8% -4.4% $15,910,444 -$709,168 2,206,719 -4.3% The Vanguard Group 30 Sep 2025

As of 30 Sep 2025, 114 institutional investors reported holding 14,454,900 shares of CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR). This represents 32% of the company’s total 45,782,552 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) together control 27% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 6.3% 2,870,172 -3.8% 0% $20,693,940
VANGUARD GROUP INC 4.8% 2,206,719 -4.3% 0% $15,910,444
GEODE CAPITAL MANAGEMENT, LLC 2.1% 961,566 -0.16% 0% $6,934,347
STATE STREET CORP 1.8% 801,344 -45% 0% $5,777,690
MORGAN STANLEY 1.2% 551,694 +0.2% 0% $3,977,714
Pier Capital, LLC 1.1% 496,554 +35% 0.56% $3,580,154
J. Goldman & Co LP 1.1% 481,981 0.13% $3,475,083
DG Capital Management, LLC 1% 470,333 2% $3,391,101
NATIONAL BANK OF CANADA /FI/ 0.87% 397,700 +136% 0% $2,867,417
TWO SIGMA INVESTMENTS, LP 0.78% 355,796 +128% 0% $2,565,289
NORTHERN TRUST CORP 0.77% 352,521 -4.9% 0% $2,541,677
Black Diamond Financial, LLC 0.61% 277,737 0% 0.22% $2,002,484
Ikarian Capital, LLC 0.58% 264,642 0.43% $1,908,069
GSA CAPITAL PARTNERS LLP 0.47% 215,675 0.13% $1,555,000
MILLENNIUM MANAGEMENT LLC 0.44% 202,459 +16% 0% $1,459,729
RAYMOND JAMES FINANCIAL INC 0.42% 191,292 +1630% 0% $1,379,216
JPMORGAN CHASE & CO 0.41% 189,799 -2.8% 0% $1,368,451
GOLDMAN SACHS GROUP INC 0.38% 175,642 +144% 0% $1,266,379
HBK Sorce Advisory LLC 0.37% 170,577 +34% 0.03% $1,141,160
CITADEL ADVISORS LLC 0.33% 150,522 0% $1,085,263
OPPENHEIMER & CO INC 0.3% 135,413 -17% 0.01% $976,328
WELLINGTON MANAGEMENT GROUP LLP 0.29% 132,315 +0.33% 0% $953,992
Quinn Opportunity Partners LLC 0.28% 128,338 0.07% $925,317
UBS Group AG 0.27% 124,717 -77% 0% $899,210
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.26% 120,285 0% 0% $867,255

Institutional Holders of CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,533 $73,104 -$350,904 $28.86 4
2025 Q3 14,454,900 $104,097,739 +$3,051,758 $7.21 114
2025 Q2 13,740,752 $136,510,446 -$45,087,125 $9.93 105
2025 Q1 18,332,527 $174,018,005 +$4,472,871 $9.49 120
2024 Q4 17,327,955 $239,127,553 +$123,239,591 $13.80 107
2024 Q3 8,369,327 $127,297,422 +$33,779,392 $15.21 75
2024 Q2 6,426,234 $30,652,576 +$6,579,081 $4.77 60
2024 Q1 4,817,759 $32,711,658 +$5,474,658 $6.79 55
2023 Q4 4,019,035 $19,652,993 -$3,283,556 $4.89 37
2023 Q3 5,536,583 $18,934,429 +$9,929,580 $3.42 34
2023 Q2 2,624,364 $12,543,954 +$927,959 $4.78 32
2023 Q1 2,433,746 $10,269,762 -$1,225,035 $4.22 30
2022 Q4 2,739,017 $10,569,409 -$271,547 $3.86 31
2022 Q3 2,792,373 $16,752,192 +$1,609,613 $6.00 28
2022 Q2 2,543,515 $8,872,518 -$139,327 $3.49 27
2022 Q1 2,589,186 $8,879,200 +$964,475 $3.43 26
2021 Q4 2,320,262 $6,798,547 -$740,098 $2.93 24
2021 Q3 2,490,642 $10,025,330 -$5,545,456 $4.02 25
2021 Q2 3,528,427 $18,097,220 -$4,296,483 $5.13 26
2021 Q1 4,384,650 $20,517,844 +$13,558,859 $4.68 28
2020 Q4 1,499,334 $5,140,899 +$692,978 $3.43 24
2020 Q3 1,264,478 $6,640,688 +$1,920,376 $5.25 25
2020 Q2 940,377 $4,324,870 +$2,983,542 $4.60 30
2020 Q1 498,312 $597,000 +$332,841 $1.20 15
2019 Q4 214,939 $275,000 +$78,218 $1.29 11
2019 Q3 123,654 $459,000 +$151,133 $3.73 15
2019 Q2 84,706 $281,000 +$281,000 $3.33 10